Advertisement
Research Article| Volume 44, ISSUE 4, P233-236, December 1991

Effects of aldose reductase inhibitors on prostacyclin (PGI2) synthesis by aortic rings from rats with streptozotocin-induced diabetes

DOI:https://doi.org/10.1016/0952-3278(91)90022-W
Effects of aldose reductase inhibitors on prostacyclin (PGI2) synthesis by aortic rings from rats with streptozotocin-induced diabetes
Previous ArticleEvaluation of prostaglandin E1 for prevention of respiratory failure in high risk trauma patients: A prospective clinical trial and correlation with plasma suppressive factors for neutrophil activation
Next ArticleInhibition by prostacyclin and carbacyclins of endothelin-induced DNA synthesis in cultured vascular smooth muscle cells
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      The effects of aldose reductase inhibitors (ARIs) on the synthesis of prostacyclin (PGI2) by aortic rings from diabetic rats were examined. The ARIs studied were ONO-2235 and isoliquiritigenin, a new compound extracted from glycyrrhizae radix. The content of sorbitol in the sciatic nerve of diabetic rats induced by streptozotocin was significantly increased as compared with that of controls. This increase was significantly inhibited by the administration of an ARI. On the other hand, there was a marked decrease in the synthesis of PGI2 by the diabetic rats compared with the control rats. The decrease in PGI2 synthesis was significantly reversed by the administration of an ARI. Furthermore, the synthesis of PGI2 by the aortic rings was inversely correlated with the content of sorbitol in sciatic nerves. Those observations suggest that an ARI may have a beneficial effect on the vascular synthesis of PGI2 in diabetes mellitus.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Prostaglandins, Leukotrienes and Essential Fatty Acids
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Kannel WB
        • McGee DL
        Diabetes and cardiovascular disease.
        The Journal of the American Medical Association. 1979; 241: 2035-2038
        • Heyden S
        • Heiss G
        • Bortel AG
        • Hames CG
        Sex differences in coronary mortality among diabetics in Evans County, Georgia.
        Journal of Chronic Diseases. 1980; 33: 265-273
        • Gabbay KH
        Hyperglycemia polyol metabolism and complications of diabetes mellitus.
        Annual Review of Medicine. 1975; 26: 521-536
        • Morrison AD
        • Orci L
        • Perrelet A
        • Winegrad AI
        Studies of the effects of an elevated glucose concentration on the ultrastructure and composite metabolism of the intact rabbit aortic intima-media preparation.
        Diabetes. 1979; 28: 720-723
        • Brownlee M
        • Cerami A
        The biochemistry of the complications of diabetes mellitus.
        Annual Review of Biochemistry. 1981; 50: 385-432
        • Cogan DG
        • Kinoshita JH
        • Kador PF
        • Robison WG
        • Datilis MB
        • Cobo LM
        • Kupfer C
        NIH CONFERENCE. Aldose reductase and complications of diabetes.
        in: Annals of Internal Medicine. 101. 1984: 82-91
        • Kador PF
        • Robison Jr., WG
        • Kinoshita JH
        The Pharmacology of aldose reductase inhibitors.
        Annual Review of Pharmacology and Toxicology. 1985; 25: 691-714
        • Raskin P
        • Rosenstock J
        Aldose reductase inhibitors and diabetic complications.
        The American Journal of Medicine. 1987; 83: 298-306
        • Aida K
        • Tawata M
        • Shindo H
        • Onaya T
        Clinical significance of erythrocyte sorbitol to blood glucose ratios in type II diabetes.
        Diabetes Care. 1990; 13: 461-467
        • Subbiah MTR
        • Deitemeyer D
        Altered synthesis of prostaglandin in platelet and aorta from spontaneously diabetic Wistar rats.
        Biochemical Medicine. 1980; 23: 231-235
        • Harrison HE
        • Reece AH
        • Johnson M
        Decreased vascular prostacyclin in experimental diabetes.
        Life Sciences. 1978; 23: 351-356
        • Kazama Y
        • Kanemaru Y
        • Noguchi T
        • Onaya T
        Reevaluation of circulating prostacyclin and thromboxane in diabetes.
        Prostaglandins Leukotrienes and Medicine. 1987; 26: 115-122
        • Aida K
        • Tawata M
        • Shindo H
        • Onaya T
        • Sasaki H
        • Yamaguchi T
        • Chin M
        • Mitsuhashi H
        Isoliquiritigenin, a new aldose reductase inhibitor from glycyrrhizae radix.
        Planta Medica. 1990; 56: 254-258
        • Noguchi T
        • Kazama Y
        • Kanemaru Y
        • Onaya T
        The effects of thyroxine and methimazole treatment on the synthesis of prostacyclin (PGI2) in the rat.
        Prostaglandins. 1985; 30: 553-561
        • Malone JI
        • Knox G
        • Benford S
        • Tedesco TA
        Red cell sorbitol. An indicator of diabetic control.
        Diabetes. 1980; 29: 861-864
        • Greene DA
        • Lattimer S
        • Ulbrecht J
        • Carroll P
        Glucose-induced alterations in nerve metabolism: current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy.
        Diabetes Care. 1985; 8: 290-299
        • Greene DA
        • Lattimer SA
        • Sima AAF
        Sorbitol, phosphoinositides and sodium-potassium-ATPase in the pathogenesis of diabetic complications.
        The New England Journal of Medicine. 1987; 316: 599-606
        • Moncada S
        • Gryglewski RJ
        • Bunting S
        • Vane JR
        An enzyme isolated from arteries transforms prostaglandin endoperoxide to an unstable substance that inhibits platelet aggregation.
        Nature. 1976; 263: 663-665
        • Needleman P
        • Minkes M
        • Raz A
        Thromboxanes: selective biosynthesis and distinct biological properties.
        Science. 1976; 193: 163-165
        • Moncada S
        • Vane JR
        Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls.
        The New England Journal of Medicine. 1979; 300: 1142-1147
        • Pitt B
        • Shea MJ
        • Romson JL
        • Lunchesi BR
        Prostaglandins and prostaglandin inhibitors in ischemic heart disease.
        Annual of Internal Medicine. 1983; 99: 83-92

      Article info

      Publication history

      Accepted: July 3, 1991
      Received: May 3, 1991

      Identification

      DOI: https://doi.org/10.1016/0952-3278(91)90022-W

      Copyright

      © 1991 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX